M&A Deal Summary

Eurofins Discovery Acquires Discovery Biomed

On July 5, 2022, Eurofins Discovery acquired life science company Discovery Biomed

Acquisition Highlights

This is Eurofins Discovery’s 1st transaction in the Life Science sector.
This is Eurofins Discovery’s 1st transaction in the United States.
This is Eurofins Discovery’s 1st transaction in Alabama.

M&A Deal Summary
Date	2022-07-05
Target	Discovery Biomed
Sector	Life Science
Buyer(s)	Eurofins Discovery
Deal Type	Add-on Acquisition

Target

Discovery Biomed

Birmingham, Alabama, United States

Discovery Biomed is an operator of boutique biotechnology company seeks to contribute to improvements in human health through its expertise, work, and facilities by providing partners and clients with pilot screening and high-throughput screening (HTS) services for therapeutic-related bioassays, providing partners and clients with custom immortalized cell lines, and performing therapeutics discovery for certain failure-to-secrete diseases in humans. Discovery Biomed was founded in 2007 and is based in Birmingham, Alabama.

Search 200,500 Deals Now

SEARCH BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer